Olema Pharmaceuticals, Inc. (OLMA)
7.20
-0.16
(-2.17%)
USD |
NASDAQ |
Oct 13, 09:44
Olema Pharmaceuticals Price to Book Value : 1.462 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 1.495 |
| October 09, 2026 | 1.588 |
| October 08, 2026 | 1.588 |
| October 07, 2026 | 1.613 |
| October 06, 2026 | 1.609 |
| October 05, 2026 | 1.676 |
| October 02, 2026 | 1.671 |
| October 01, 2026 | 1.680 |
| September 30, 2026 | 1.755 |
| September 29, 2026 | 1.735 |
| September 28, 2026 | 1.749 |
| September 25, 2026 | 1.777 |
| September 24, 2026 | 1.836 |
| September 23, 2026 | 1.794 |
| September 22, 2026 | 1.958 |
| September 21, 2026 | 1.956 |
| September 18, 2026 | 1.994 |
| September 17, 2026 | 2.011 |
| September 16, 2026 | 1.976 |
| September 15, 2026 | 1.986 |
| September 14, 2026 | 2.09 |
| September 11, 2026 | 2.076 |
| September 10, 2026 | 2.171 |
| September 09, 2026 | 2.104 |
| September 08, 2026 | 2.231 |
| Date | Value |
|---|---|
| September 04, 2026 | 2.183 |
| September 03, 2026 | 2.179 |
| September 02, 2026 | 2.200 |
| September 01, 2026 | 2.145 |
| August 31, 2026 | 2.118 |
| August 28, 2026 | 2.086 |
| August 27, 2026 | 2.192 |
| August 26, 2026 | 2.204 |
| August 25, 2026 | 2.216 |
| August 24, 2026 | 2.118 |
| August 21, 2026 | 2.171 |
| August 20, 2026 | 2.214 |
| August 19, 2026 | 2.297 |
| August 18, 2026 | 2.163 |
| August 17, 2026 | 2.188 |
| August 14, 2026 | 2.159 |
| August 13, 2026 | 2.135 |
| August 12, 2026 | 2.120 |
| August 11, 2026 | 2.118 |
| August 10, 2026 | 2.425 |
| August 07, 2026 | 2.448 |
| August 06, 2026 | 2.397 |
| August 05, 2026 | 2.352 |
| August 04, 2026 | 2.389 |
| August 03, 2026 | 2.291 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| SELLAS Life Sciences Group, Inc. | 17.66 |
| ACADIA Pharmaceuticals, Inc. | 2.479 |
| Alnylam Pharmaceuticals, Inc. | 22.33 |
| Anika Therapeutics, Inc. | 1.996 |
| Savara, Inc. | 6.963 |
Price to Book Value Related Metrics
| PEG Ratio | -0.3347 |
| Price | 7.20 |
| Earnings Yield | -29.42% |
| Market Cap | 629.66M |
| PEGY Ratio | -0.3347 |